<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-MRT-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Mauritania: Targeted country assistance</narrative>
   <narrative xml:lang="FR">Mauritanie (la): Aide cibl&#xE9;e aux pays</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">EpiLinks</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="US-EIN-91-1157127" role="4">
   <narrative xml:lang="EN">PATH</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Mauritania</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="MR" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="MR" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Nouakchott</narrative>
   </name>
   <administrative code="MR" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>18.10033 -15.94975</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1200774</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1257847</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1087076</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">51157.32</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">51157.32</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="MRTPEF-TCA-AEDES2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">5586</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MRTPEF-TCA-EPILINKS2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">115305</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-EPILINKS (EpiLinks)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">EpiLinks</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MRTPEF-TCA-LEHBIB2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">5226</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-LEHBIB</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="MRTPEF-TCA-PATH2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">50256</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MRTPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">8594</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MRTPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">455696</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MRTPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">560111</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MRTPEF-TCA-EPILINKS2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-EPILINKS (EpiLinks)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">EpiLinks</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MRTPEF-TCA-PATH2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">105909</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MRTPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">27714</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MRTPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">505764</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MRTPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">618460</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MRTPEF-TCA-PATH2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">21658</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MRTPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">31638</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MRTPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">500346</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MRTPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">533435</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000995">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">31810</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EPILINKS (EpiLinks)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">EpiLinks</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001158">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">63519</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EPILINKS (EpiLinks)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">EpiLinks</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001299">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-21105</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EPILINKS (EpiLinks)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">EpiLinks</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900003826">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-31"></transaction-date>
   <value currency="USD" value-date="2019-08-31">41081</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EPILINKS (EpiLinks)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">EpiLinks</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000996">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">-3153</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-LEHBIB</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900001159">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">8379</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-LEHBIB</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">50256</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001178">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-14"></transaction-date>
   <value currency="USD" value-date="2020-05-14">75000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002734">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-06"></transaction-date>
   <value currency="USD" value-date="2020-07-06">25608</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-5301</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">5301</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">7604</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-513</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">804</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001193">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-29"></transaction-date>
   <value currency="USD" value-date="2020-03-29">14911</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-7638</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">7638</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000297">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-03"></transaction-date>
   <value currency="USD" value-date="2021-02-03">1988</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">1425</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">150</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">75</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000845">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">455695</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">455760</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">50004</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002314">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-25"></transaction-date>
   <value currency="USD" value-date="2021-05-25">96120</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002681">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">404226</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000846">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">560111</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">559610</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">58850</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002722">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">397371</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002910">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-29"></transaction-date>
   <value currency="USD" value-date="2021-06-29">136064</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-mauritania-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Mauritania 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-mauritania-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Mauritania 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-mauritania-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Mauritania 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-mauritania-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Mauritania 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-mauritania-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Mauritania 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-mauritania-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Mauritania 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-mauritania-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Mauritania 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-mauritania-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Mauritania 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-05-31"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-MRT" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le plan strat&#xE9;gique de communication pour le soutien du programme, les outils et supports de communication sont disponibles ; Le plan de communication RR2 ainsi que sa mise en oeuvre est realise.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Appui &#xE0; d&#xE9;veloppement d&apos; un manuel de CIP dans les soins de sant&#xE9; primaires (RSS) 2. l&apos;&#xE9;laboration et &#xE0; la mise en ?uvre du plan de communication RR2 
3. Appui a l&apos;actualisation du plan de communication pour le soutien du PEV ; 4. Elaboration de la strategie d&apos;appui a la reduction d&apos;enfants non vaccines a Nouakchott">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">1.	Cette activit&#xE9; relative &#xE0; la mise en ?uvre du RSS a &#xE9;t&#xE9; report&#xE9;e 
2.	L?introduction de la 2eme dose est retard&#xE9;e au premier trimestre 2022 &#xE0; cause des campagnes Covid-19 et riposte polio 
Les activit&#xE9;s RSS ont &#xE9;t&#xE9; retard&#xE9;e &#xE0; cause des manuels de proc&#xE9;dures comptables relatives au d&#xE9;caissement des fonds ;
3.	Le processus de revue du PEV, et de la strat&#xE9;gie nationale de l?immunisation ( SNI) y compris le plan de communication consolid&#xE9; du PEV ont &#xE9;t&#xE9; retard&#xE9;e &#xE0; cause des flamb&#xE9;es du COVID et des campagnes de vaccination .Le bureau de l?UNICEF s?est engag&#xE9; dans la mise en ?uvre d?approches communautaires int&#xE9;gr&#xE9;es et d&#xE9;veloppe des synergies entre les approches sectorielles. Des outils communs qui renforcent la participation et la CIP entre les prestataires des services et les demandeurs de l?offre sont en cours de d&#xE9;veloppement dans ce cadre. Un consultant national est en cours de recrutement pour appuyer les processus d?actualisation du plan de communication et d?introduction du vaccin RR, L?assistance technique en C4D en 2021 s?est grandement focalis&#xE9;e sur la r&#xE9;ponse a l?&#xE9;pid&#xE9;mie Covid par l?organisation des enqu&#xEA;tes pr&#xE9; et post campagne de distribution des vaccins ; la planification de la communication pour susciter la demande y compris la mise en place des m&#xE9;canismes pour att&#xE9;nuer les rumeurs. 
Les contributions de l?UNICEF se poursuivent pour la finalisation du plan d?appui &#xE0; la r&#xE9;duction d?enfants non vaccin&#xE9;s int&#xE9;grant la strat&#xE9;gie de communication qui demande une participation communautaire.
4.	La strat&#xE9;gie de promotion de la demande de vaccination relativement au plan d?am&#xE9;lioration de la couverture vaccinale &#xE0; Nouakchott est en cours de r&#xE9;alisation concomitant avec la mise en ?uvre du plan de Nouakchott en s?appuyant sur les relais communautaires recrut&#xE9;s dans les zones difficiles d?acc&#xE8;s et non couverts par la les formations sanitaires</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le plan de communication pour la vaccination de routine est &#xE9;labor&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Appuyer l?introduction de la deuxi&#xE8;me dose RR


2. Appuyer l?introduction du vaccin HPV

3. Appuyer la revision et l&apos;&#xE9;laboration du plan de communication pour la vaccination de routine y integrant les modules de vaccination de la deuxieme ann&#xE9;e de vie et les orientations du nouveau guide de l&apos;approche ACD y compris l&apos;introduction HPV

4. Appuyer la mise en oeuvre du processus de formation supervision et coaching CIP dans 3 regions du pays y compris l&apos;elaboration des outils de communication">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">L&apos;unicef a apport&#xE9; l&apos;appui technique &#xE0; l&apos;introduction du vaccin HPV dans le contexte particulier du covid -19 
Par l&apos;adaptation du plan de communication , des messages et des outils de vulgarisation et commence dans la preparation de la deuxieme dose un taux de 42% a &#xE9;t&#xE9; atteint chez les filles de 9 &#xE0; 14 ans , la preparation de l&apos;introduction de la second dose de RR est en cours de planification , le plan de communication est planifi&#xE9; dans le POA du ministere dans 3 eme trimestre 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Appuyer l?introduction de la deuxi&#xE8;me dose RR


2. Appuyer l?introduction du vaccin HPV

3. Appuyer la revision et l&apos;&#xE9;laboration du plan de communication pour la vaccination de routine y integrant les modules de vaccination de la deuxieme ann&#xE9;e de vie et les orientations du nouveau guide de l&apos;approche ACD y compris l&apos;introduction HPV

4. Appuyer la mise en oeuvre du processus de formation supervision et coaching CIP dans 3 regions du pays y compris l&apos;elaboration des outils de communication">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">L&apos;unicef a apport&#xE9; l&apos;appui technique &#xE0; l&apos;introduction du vaccin HPV dans le contexte particulier du covid -19 
Par l&apos;adaptation du plan de communication , des messages et des outils de vulgarisation et commence dans la preparation de la deuxieme dose un taux de 42% a &#xE9;t&#xE9; atteint chez les filles de 9 &#xE0; 14 ans , la preparation de l&apos;introduction de la second dose de RR est en cours de planification , le plan de communication est planifi&#xE9; dans le POA du ministere dans 3 eme trimestre 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Une strategie d&apos;appui a la r&#xE9;duction d&apos;enfants non vaccines a Nouakchot est realisee</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Appui &#xE0; d&#xE9;veloppement d&apos; un manuel de CIP dans les soins de sant&#xE9; primaires (RSS) 2. l&apos;&#xE9;laboration et &#xE0; la mise en ?uvre du plan de communication RR2 
3. Appui a l&apos;actualisation du plan de communication pour le soutien du PEV ; 4. Elaboration de la strategie d&apos;appui a la reduction d&apos;enfants non vaccines a Nouakchott">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Un plan d&apos;amelioration de couverture vaccinale est en cours de mise en oeuvre dans les 3 wilaya de Nouakchott afin d&apos;ameliorer l&apos;acces equitable de la vaccination en milieu urbain</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in HPV review meetings completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to MOH to monitor HPV implemention of dose 2 improvements, progress, identify challenges, propose solutions (2020)">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Activity to follow dose 2 implementation- Tentative date December. Activity to be reschedule to Q 1/Q2 2022</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to MOH to monitor HPV implemention of dose 1 improvements, progress, identify challenges, propose solutions">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">PATH is a member of the committee that is reviewing activities for vaccination campaign</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV PIE, coverage survey, and costing protocols completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Finalize HPV PIE, coverage survey, costing protocols for national evaluation">
      <location ref="MR"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Activity to follow dose 2 implementation - Tentative date December. Activity to be reschedule to Q 1/Q2 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV PIE report completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participate in HPV PIE for select districts in the national evaluation">
      <location ref="MR"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Activity to follow dose 2 implementation- Tentative date December. Activity to be reschedule to Q 1/Q2 2022.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participate in HPV PIE for a few districts in from first phase of national intro in 4 regions (2020)">
      <location ref="MR"></location>
     </target>
     <actual>
      <location ref="MR"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV coverage survey implemented and report completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Prepare logistics for HPV coverage survey for selected districts in the national evaluation">
      <location ref="MR"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Activity to follow dose 2 implementation- Tentative date December. Activity to be reschedule to Q 1/Q2 2022.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implement HPV coverage survey for a few districts in from first phase of national intro in 4 regions (2020)">
      <location ref="MR"></location>
     </target>
     <actual>
      <location ref="MR"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV costing evaluation report completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implement HPV costing for dose 1 in selected districts for the national evaluation">
      <location ref="MR"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Activity was delayed, but data collection has started and is ongoing.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implement HPV costing for a few districts in from first phase of national intro in 4 regions (2020)">
      <location ref="MR"></location>
     </target>
     <actual>
      <location ref="MR"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training plans and materials finalized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist with development of training plans and materials for HPV introduction">
      <location ref="MR"></location>
     </target>
     <actual value="Completed">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Completed; documents were revised and finalized in March 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV costing evaluation field data collection completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implement HPV costing for dose 1 in selected districts for the national evaluation">
      <location ref="MR"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Activity was delayed, but data collection has started and is ongoing.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implement HPV costing for dose 1 in selected districts for the national evaluation">
      <location ref="MR"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Costing evaluation may start in Q3 2021 when a new PATH Health Economist will be onboarded.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV coverage survey implementation plan finalized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Prepare logistics for HPV coverage survey for selected districts in the national evaluation">
      <location ref="MR"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Activity to follow dose 2 implementation- Tentative date December. Activity to be reschedule to Q 1/Q2 2022.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Prepare logistics for HPV coverage survey for selected districts in the national evaluation">
      <location ref="MR"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Coverage survey planned for later in the year (early December).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in HPV readiness assessment completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participation in readiness assessment for HPV introduction (scheduled for Apr 2021)">
      <location ref="MR"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Mauritania has not completed readiness assessment.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV PIE, coverage survey, and costing protocols drafted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Begin HPV PIE, coverage survey, costing protocols for national evaluation">
      <location ref="MR"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Activity to follow dose 2 implementation- Tentative date December. Activity to be reschedule to Q 1/Q2 2022</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Begin HPV PIE, coverage survey, costing protocols for national evaluation">
      <location ref="MR"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Ongoing discussions to plan for the PIE and costing evaluations.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in continued dose 1 review meetings completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to MOH to monitor HPV implemention progress, identify challenges, propose solutions">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">PATH contributed to the monitoring of the vaccination campaign and discussions to improve coverage.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to MOH to monitor HPV implemention progress, identify challenges, propose solutions">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">PATH submitted a presentation to the MOH on the challenges encountered since the decision to introduce the HPV vaccine in Mauritania and explain to Gavi why more than 100,000 doses have expired this year and could not be used.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">National TOT conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participate in national TOT for HPV introduction">
      <location ref="MR"></location>
     </target>
     <actual value="Completed">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">PATH participated in national TOT.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV PIE implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participate in HPV PIE for select districts in the national evaluation">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">PIE is led by WHO, and the dates have not been shared yet.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support to and attendance at planning and TWG meetings is completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Nat?l planning and TWG meetings for HPV intro (routine+MAC)">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">PATH participated in the HPV TWG. Documents for the launch, training and monitoring, were developed during these meetings.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Nat?l planning and TWG meetings for HPV intro (routine+MAC)">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Weekly meetings have been held with the MOH, GAVI, WHO, UNICEF and PATH to discuss planning of the second HPV campaign. PATH is also supporting planning of communication activities. Expected launch date is December 8, 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in HPV review meetings completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to MOH to monitor HPV implemention of dose 2 improvements, progress, identify challenges, propose solutions (2020)">
      <location ref="MR"></location>
     </target>
     <actual>
      <location ref="MR"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Un inventaire complet des equipements de chaines de froid est realis&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Appui aux reunions du PMT et suivi du plan d&apos;approvisionnement de la CCEOP
2. Suivi et supervisions de la mise en ?uvre du plan de deploiement de la CCEOP sur le terrain. 
3. Former 20 techniciens de froid.sur la maintenance des equipements de CDF solaires 
4. Appuyer la mise en ?uvre de l?inventaire des ECF">
      <location ref="MR"></location>
     </target>
     <actual value="Completed">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Le projet de la CCEOP a &#xE9;t&#xE9; r&#xE9;alis&#xE9; dans de bonnes conditions d&apos;efficacit&#xE9; seulement 5/404 &#xE9;quipements ont &#xE9;t&#xE9; d&#xE9;vi&#xE9;s de leur destination d&apos;origine mais install&#xE9;s dans la m&#xEA;me Moughataa. Par la suite un inventaire a &#xE9;t&#xE9; r&#xE9;alis&#xE9; pour r&#xE9;actualiser les donn&#xE9;es du parc d&apos;&#xE9;quipement a la suite de cet important investissement ce qui a permis une bonne pr&#xE9;disposition &#xE0; la pr&#xE9;paration du pays &#xE0; la vaccination anti-covid-19 dans le cadre de la plateforme COVAX 
A cause des mesures de pr&#xE9;vention de la pand&#xE9;mie l&apos;activit&#xE9; de formation des techniciens de froid bien que planifi&#xE9;e dans le POA du minist&#xE8;re de la sant&#xE9; a &#xE9;t&#xE9; jug&#xE9;e non prioritaire et a gliss&#xE9; dans le POA 2021
Un inventaire complet national est planifi&#xE9; dans le POA 2021 et ses TDR sont d&#xE9;j&#xE0; &#xE9;labor&#xE9;s et la requ&#xEA;te est en cours de traitement</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Appui aux reunions du PMT et suivi du plan d&apos;approvisionnement de la CCEOP
2. Suivi et supervisions de la mise en ?uvre du plan de deploiement de la CCEOP sur le terrain. 
3. Former 20 techniciens de froid.sur la maintenance des equipements de CDF solaires 
4. Appuyer la mise en ?uvre de l?inventaire des ECF">
      <location ref="MR"></location>
     </target>
     <actual value="Completed">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Le projet de la CCEOP a &#xE9;t&#xE9; r&#xE9;alis&#xE9; dans de bonnes conditions d&apos;efficacit&#xE9; seulement 5/404 &#xE9;quipements ont &#xE9;t&#xE9; d&#xE9;vi&#xE9;s de leur destination d&apos;origine mais install&#xE9;s dans la m&#xEA;me Moughataa. Par la suite un inventaire a &#xE9;t&#xE9; r&#xE9;alis&#xE9; pour r&#xE9;actualiser les donn&#xE9;es du parc d&apos;&#xE9;quipement a la suite de cet important investissement ce qui a permis une bonne pr&#xE9;disposition &#xE0; la pr&#xE9;paration du pays &#xE0; la vaccination anti-covid-19 dans le cadre de la plateforme COVAX 
A cause des mesures de pr&#xE9;vention de la pand&#xE9;mie l&apos;activit&#xE9; de formation des techniciens de froid bien que planifi&#xE9;e dans le POA du minist&#xE8;re de la sant&#xE9; a &#xE9;t&#xE9; jug&#xE9;e non prioritaire et a gliss&#xE9; dans le POA 2021
Un inventaire complet national est planifi&#xE9; dans le POA 2021 et ses TDR sont d&#xE9;j&#xE0; &#xE9;labor&#xE9;s et la requ&#xEA;te est en cours de traitement</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Un manuel de gestion des services de sant&#xE9; est disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Appui technique au d&#xE9;veloppement d&apos;un manuel de gestion des services de sant&#xE9; 2. Appui technique de la formation des 57 M&#xE9;decins chefs des &#xE9;quipes de Moughataa en sant&#xE9; publique/Gestion technique des moughataa 3. Asssitance technique &#xE0; tout le programme d&apos;action &#xE0; Nktt (la r&#xE9;duction des enfants z&#xE9;ro dose &#xE0; Nouakchott &#xE0; travers une approche communautaire) 4. Appui au suivi et &#xE0; l?extension de la strat&#xE9;gie ACD dans les Wilayas (HEC, GOR, GUI, BRA, Ass): Microplanification , monitorage, supervision , integration 
5. Appui technique au d&#xE9;veloppement d&apos;un guide d&apos;organisation des activit&#xE9;s mobiles inegrant les interventions essentielles de SMINA">
      <location ref="MR"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">L&apos;activit&#xE9; a gliss&#xE9; dans le POA au troisieme trimestre</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Appui technique au d&#xE9;veloppement d&apos;un manuel de gestion des services de sant&#xE9; 2. Appui technique de la formation des 57 M&#xE9;decins chefs des &#xE9;quipes de Moughataa en sant&#xE9; publique/Gestion technique des moughataa 3. Asssitance technique &#xE0; tout le programme d&apos;action &#xE0; Nktt (la r&#xE9;duction des enfants z&#xE9;ro dose &#xE0; Nouakchott &#xE0; travers une approche communautaire) 4. Appui au suivi et &#xE0; l?extension de la strat&#xE9;gie ACD dans les Wilayas (HEC, GOR, GUI, BRA, Ass): Microplanification , monitorage, supervision , integration 5. Appui technique au d&#xE9;veloppement d&apos;un guide d&apos;organisation des activit&#xE9;s mobiles inegrant les interventions essentielles de SMINA">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Les 10 Districts ACD sont suivies par un consultant qui assure l?appui technique au DRAS, MCM et points focaux vaccination.
- un rapportage mensuel des donn&#xE9;es de la vaccination dans les 10 Moughataas et un feedback sont assur&#xE9;s.
- Une supervision formative a &#xE9;t&#xE9; organis&#xE9; au niveau des 10 Moughataas pour instaurer l?utilisation du diagramme de suivi et de monitorage de la vaccination. 
(Diagramme affich&#xE9; dans les structures de sant&#xE9;).
-Un atelier de l?&#xE9;quit&#xE9; a &#xE9;t&#xE9; organis&#xE9; au niveau de la Wilaya du Brakna au profit de l?&#xE9;quipe DRAS et les 5 m&#xE9;decins chefs des moughataa de la r&#xE9;gion. 
Les plans d?action des Moughataas sont en cours d?&#xE9;laboration avec l?appui technique du consultant ACD. L?UNICEF a poursuivi sa contribution dans les documents strat&#xE9;gique : PNDS, Dossier d?investissement GFF et le processus d?&#xE9;laboration de la strat&#xE9;gie nationale Sant&#xE9; reproduction, maternelle n&#xE9;onatale, infantile adolescent et nutrition ( SRMNIA-Nutrition) 
Cette activit&#xE9; d&#xE9;pend &#xE9;galement des fonds RSS, elle n?a pas &#xE9;t&#xE9; encore ex&#xE9;cut&#xE9;e.
(Les outils d?analyse des goulots d?&#xE9;tranglement de la vaccination AGE disponible)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Un rapport de la formation des 57 M&#xE9;decins chefs des &#xE9;quipes de Moughataa en sant&#xE9; publique est disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Appui technique au d&#xE9;veloppement d&apos;un manuel de gestion des services de sant&#xE9; 2. Appui technique de la formation des 57 M&#xE9;decins chefs des &#xE9;quipes de Moughataa en sant&#xE9; publique/Gestion technique des moughataa 3. Asssitance technique &#xE0; tout le programme d&apos;action &#xE0; Nktt (la r&#xE9;duction des enfants z&#xE9;ro dose &#xE0; Nouakchott &#xE0; travers une approche communautaire) 4. Appui au suivi et &#xE0; l?extension de la strat&#xE9;gie ACD dans les Wilayas (HEC, GOR, GUI, BRA, Ass): Microplanification , monitorage, supervision , integration 
5. Appui technique au d&#xE9;veloppement d&apos;un guide d&apos;organisation des activit&#xE9;s mobiles inegrant les interventions essentielles de SMINA">
      <location ref="MR"></location>
     </target>
     <actual value="Completed">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Les activit&#xE9;s 1,2 et 5 qui &#xE9;taient li&#xE9;es &#xE0; la mise en ?uvre du RSS par le minist&#xE8;re de la sant&#xE9; qui a pris un retard consid&#xE9;rable dans processus de validation du manuel de proc&#xE9;dure et de d&#xE9;caissement ajout&#xE9; &#xE0; cela l?occupation du personnel de sant&#xE9; dans les campagnes de vaccination contre la COVID-19.
Ces activit&#xE9;s n?ont pu &#xEA;tre r&#xE9;alis&#xE9;es 
Le pilote de l?approche communautaire mis en ?uvre dans la strat&#xE9;gie urbaine pour la r&#xE9;duction des enfants ZERO doses en collaboration avec les leaders communautaires, les communes et les DRAS comprenait plusieurs &#xE9;tapes :
1.	Etapes de concertations avec les diff&#xE9;rentes parties prenantes 
2.	Etapes de cartographie des poches de pauvret&#xE9;s ,de vuln&#xE9;rabilit&#xE9;s , des populations difficiles d?acc&#xE8;s et l?identification de relais communautaires , leaders communautaires issus des quartiers vuln&#xE9;rables
3.	Microplanifications et &#xE9;laboration de microplan par Moughataa
4.	Financement et mise en ?uvre des microplans pour la r&#xE9;solution des goulots d?&#xE9;tranglement et la mitigation des vuln&#xE9;rabilit&#xE9;s &#xE0; l?acc&#xE8;s de la vaccination 
5.	Am&#xE9;lioration de l?offre en comp&#xE9;tence des ressources humaines, en intrants et en accessibilit&#xE9; par la mise en place de site avanc&#xE9;e dans les quartiers difficiles d?acc&#xE8;s et la formation du personnel sur la gestion des vaccins, le monitorage pour action et supervision formative
Le financement est mis en place et les activit&#xE9;s de mise en ?uvre sont en cours pour 4 Mois.
L?Unicef a fourni de l?assistance technique dans la note de conceptuelle de Fonds mondial (NFM3) pour s?assurer de la prise en compte du volet communautaire o&#xF9; les relais contribueront au suivi de la compl&#xE9;tude du statut vaccinal des enfants.
 La formation des m&#xE9;decins du niveau op&#xE9;rationnel a &#xE9;t&#xE9; ax&#xE9;e sur la prise en charge des cas de COVID19, la pr&#xE9;vention et le contr&#xF4;le des infections ainsi que la vaccination et la chaine de froid eu &#xE9;gard au contexte COVID. L&#xDA;NICEF a contribu&#xE9; techniquement et financi&#xE8;rement aux formations et aux supervisions</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV costing evaluation field data collection completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implement HPV costing for a few districts in from first phase of national intro in 4 regions (2020)">
      <location ref="MR"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Costing evaluation may start in July 2021 when new PATH Health Economist is on board.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV PIE, coverage survey, and costing protocols finished</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Finalize HPV PIE, coverage survey, costing protocols for a few districts in from first phase of national intro in 4 regions (2020)">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Coverage survey planned for later in the year (early December). Costing evaluation may start in July when new PATH Health Economist is on board.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in HPV readiness assessment completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participation in readiness assessment for HPV introduction">
      <location ref="MR"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Mauritania has not completed readiness assessment.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV PIE, coverage survey, and costing protocols drafted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Begin HPV PIE, coverage survey, costing protocols for a few districts in from first phase of national intro in 4 regions">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Ongoing discussions to plan for the PIE and costing evaluations.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in continued dose 1 review meetings completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to MOH to monitor HPV implemention progress, identify challenges, propose solutions">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">PATH contributed to the monitoring of the vaccination campaign and discussions to improve coverage.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to MOH to monitor HPV implemention progress, identify challenges, propose solutions">
      <location ref="MR"></location>
     </target>
     <actual>
      <location ref="MR"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV PIE implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participate in HPV PIE for a few districts in from first phase of national intro in 4 regions (2020)">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">PIE is led by WHO, and dates have not been shared yet.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">National TOT conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participate in national TOT for HPV introduction">
      <location ref="MR"></location>
     </target>
     <actual value="Completed">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Participated in TOT.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in post-launch evalation activities completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participate in rapid assessment evaluation after launch of dose 1 (2-6 weeks after HPV introduction)">
      <location ref="MR"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Rapid assessment has not been scheduled yet.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participate in rapid assessment evaluation after launch of dose 1 (2-6 weeks after HPV introduction)">
      <location ref="MR"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The Ministry of Health decided to opt review meeting instead of rapid formal assessment.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in HPV review meetings completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to MOH to monitor HPV implemention of dose 1 improvements, progress, identify challenges, propose solutions">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">PATH is a member of the committee that is reviewing activities for vaccination campaign</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to MOH to monitor HPV implemention of dose 1 improvements, progress, identify challenges, propose solutions">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">This activity is planned for November 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to MOH to monitor HPV implemention of dose 2 improvements, progress, identify challenges, propose solutions (2020)">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">This activity is planned for November 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV coverage survey implementation plan finalized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implement HPV coverage survey for a few districts in from first phase of national intro in 4 regions (2020)">
      <location ref="MR"></location>
     </target>
     <actual>
      <location ref="MR"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le rapport de l&apos;atelier d&apos;orientation des ONGs et de relais sur l&apos;identification et la r&#xE9;f&#xE9;rence pour la vaccination des enfants z&#xE9;ro dose &#xE0; Nouakchott et disponible.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Appui &#xE0; l&apos;&#xE9;laboration des documents de r&#xE9;f&#xE9;rence de la sant&#xE9; en particulier la vaccination ( Strat&#xE9;gie nationale de vaccination ) et suivi de la mise en ?uvre 
2. Appui au processus de developement de FPP 3.Appui au suivi de la planification strat&#xE9;gique (POA, RSS, TCA ...) et &#xE0; l&apos;encadrement de la nouvelle &#xE9;quipe du PEV central 4. Appui &#xE0; l&apos;organisation de la revue nationale du PEV 
5. Appui &#xE0; l&apos;&#xE9;laboration et mise en ?uvre d&apos;une strat&#xE9;gie d&apos;am&#xE9;lioration de la couverture vaccinale et la r&#xE9;duction des enfants z&#xE9;ro dose &#xE0; Nouakchott &#xE0; travers une approche communautaire (Appui &#xE0; la cartographie des ONG locales et ASC pour r&#xE9;cup&#xE9;rer les enfants z&#xE9;ro doses en collaboration avec le( SPEV, DRAS, MCM, ONGs)">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">La note conceptuelle de la strategie d&apos;am&#xE9;lioration de la couverture vaccinale dans les 3 wilayas de Nouakchott a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e et integr&#xE9;e au POA 2021 , les discussions avec les differents acteurs sont en cours pour mettre en place un plan de reduction des zero doses comprenant le PEV, les Dras de Nouakchott , les communes et les relais communautaires les activit&#xE9;s comprennent des ateliers d&apos;analyses d&apos;equit&#xE9; et identifications communaut&#xE9;s Marginales , des microplanifications au niveau des districts , du monitorage pour action et des supervision des activit&#xE9;s avanc&#xE9;es et des cartographies des ong en collaboration avec les communes et des relais communautaires de quartiers</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le rapport de la revue du PEV avec la contribution de l&apos;Unicef est disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Appui &#xE0; l&apos;&#xE9;laboration des documents de r&#xE9;f&#xE9;rence de la sant&#xE9; en particulier la vaccination ( Strat&#xE9;gie nationale de vaccination ) et suivi de la mise en ?uvre 
2. Appui au processus de developement de FPP 3.Appui au suivi de la planification strat&#xE9;gique (POA, RSS, TCA ...) et &#xE0; l&apos;encadrement de la nouvelle &#xE9;quipe du PEV central 4. Appui &#xE0; l&apos;organisation de la revue nationale du PEV 
5. Appui &#xE0; l&apos;&#xE9;laboration et mise en ?uvre d&apos;une strat&#xE9;gie d&apos;am&#xE9;lioration de la couverture vaccinale et la r&#xE9;duction des enfants z&#xE9;ro dose &#xE0; Nouakchott &#xE0; travers une approche communautaire (Appui &#xE0; la cartographie des ONG locales et ASC pour r&#xE9;cup&#xE9;rer les enfants z&#xE9;ro doses en collaboration avec le( SPEV, DRAS, MCM, ONGs)">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Pour 2021, l?appui UNICEF a &#xE9;t&#xE9; centralis&#xE9;e sur la r&#xE9;ponse COVID-19 aussi bien dans la revue et mise &#xE0; jour de la strat&#xE9;gie nationale de vaccination (PPAC), L?UNICEF a contribu&#xE9; dans la pr&#xE9;vision et l?approvisionnement, la distribution des &#xE9;quipements de protection individuel, la mise &#xE0; disposition des mat&#xE9;riels pour l?hygi&#xE8;ne, la formation &#xE0; la prise en charge. L?UNICEF a contribu&#xE9; au d&#xE9;veloppement de la strat&#xE9;gie nationale de vaccination COVID19, ses mises &#xE0; jour r&#xE9;guli&#xE8;res, l?organisation des campagnes et la mobilisation des ressources pour contribuer aux efforts du gouvernement 
Eu &#xE9;gard &#xE0; cette situation, la revue du PEV planifi&#xE9;e a connu du retard et par cons&#xE9;quent le processus du FPP est au stade de discussion.
 L?UNICEF a activement contribu&#xE9; dans la reprogrammation des fonds RSS et suit les commandes plac&#xE9;es. 
 L?UNICEF a contribu&#xE9; &#xE0; la r&#xE9;ponse polio dans la coordination, la formation des acteurs surtout dans le domaine de la gestion des vaccins 
Une strat&#xE9;gie de vaccination de Nouakchott int&#xE9;grant le suivi de la croissance et la r&#xE9;cup&#xE9;ration nutritionnelle avec l?appui des ONG partenaires de l?UNICEF a &#xE9;t&#xE9; &#xE9;labor&#xE9;e et convenue avec le Minist&#xE8;re. La mise en ?uvre d&#xE9;marre ce mois</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EPI review report is available and integrated into the national health plan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the implementation of a complete EPI review: the last review was conducted in April 2014, and it is supposed to be conducted every 5 years. In addition to this, the EPI review is prerequisite for the cMYP that will expire in 2020.">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">All the pre-requisite for EPI review has been finalized, but due to the Covid19 situation the activity could not be implemented as planned. The work should be resumed once the epidemiological situation permits.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the implementation of a complete EPI review: the last review was conducted in April 2014, and it is supposed to be conducted every 5 years. In addition to this, the EPI review is prerequisite for the cMYP that will expire in 2020.">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">All the pre-requisite for EPI review has been finalized, but due to the Covid19 situation the activity could not be implemented as planned. The work should be resumed once the epidemiological situation permits.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The survey implemented, data collected, analyzed and the report validated, and shared with different stakeholders/partners</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the implementation of a complete EPI review: the last review was conducted in April 2014, and it is supposed to be conducted every 5 years. In addition to this, the EPI review is prerequisite for the cMYP that will expire in 2020.">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">All the pre-requisite for EPI review has been finalized, but due to the Covid19 situation the activity could not be implemented as planned. The work should be resumed once the epidemiological situation permits.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support provided to country teams for AVW, new vaccines introduction, and learned lessons are documented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the ministry of health to implement the 2020 African Vaccination Week, the introduction of new vaccines, and enhance the technical capacities of the EPI staff at the central level (training workshops, )">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The HPV vaccine has been introduced in the EPI routine, and the post introductory evaluation is being prepared, and expected to be implemented by the end of July 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the ministry of health to implement the 2020 African Vaccination Week, the introduction of new vaccines, and enhance the technical capacities of the EPI staff at the central level (training workshops, )">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The HPV vaccine has been introduced in the EPI routine, and the post introductory evaluation is being prepared, and expected to be implemented by the end of July 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support to enhance technical capabilities and monitoring EPI activities is provided to country teams (central, regional and districts) for the implementation of the AVW, and new vaccines introduction,</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the ministry of health to implement the 2020 African Vaccination Week, the introduction of new vaccines, and enhance the technical capacities of the EPI staff at the central level (training workshops, )">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The HPV vaccine has been introduced in the EPI routine, and the post introductory evaluation is being prepared, and expected to be implemented by the end of July.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">By June 2021, 100% of the EPI trained personal in the 28 targeted districts have developed their own monitoring and evaluation plans to be used in their respective districts.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the MoH to train the EPI personal in the HSS2 districts/Regions, and in the regions of Dakhlet Nouadhibou and Tiris Zemour (these two regions were identified as priorities with regard to the training because of the personal that has never been trained on immunization technics">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The preparation work has started, but was temporarily suspended due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the MoH to train the EPI personal in the HSS2 districts/Regions, and in the regions of Dakhlet Nouadhibou and Tiris Zemour (these two regions were identified as priorities with regard to the training because of the personal that has never been trained on immunization technics">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The preparation work has started, but was temporarily suspended due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of the EPI district managers in the 28 targeted districts have been trained on the EPI management.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the MoH to train the EPI personal in the HSS2 districts/Regions, and in the regions of Dakhlet Nouadhibou and Tiris Zemour (these two regions were identified as priorities with regard to the training because of the personal that has never been trained on immunization technics">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The preparation work has started, but was temporarily suspended due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">the national comprehensive multi-year strategic plan is finalized, the report is validated by the end of 2020, and is used in the national health development plan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the ministry of health to develop the national comprehensive multi-year strategic plans (cMYP) for immunization">
      <location ref="MR"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The activity has not started yet du to Covid19 situation in the country including the immunization campaigns (Covid19 and HPV). It is planned to be conducted by the end of March 2022.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the ministry of health to develop the national comprehensive multi-year strategic plans (cMYP) for immunization">
      <location ref="MR"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">This activity has not started yet due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the ministry of health to develop the national comprehensive multi-year strategic plans (cMYP) for immunization">
      <location ref="MR"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">This activity has not started yet due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The data collected, analyzed and the cMYP developed, and shared with different stakeholders/partners for review and validation</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the ministry of health to develop the national comprehensive multi-year strategic plans (cMYP) for immunization">
      <location ref="MR"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">This activity has not started yet due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The TIP/recommendation plan implemented in the regions of Nouakchott Nord and Nouakchott South</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the implementation of the recommendations of the tailoring immunization program (TIP).&#xA0; approach: the TIP was conducted in 2018-2019 in the three regions of Nouakchott where more than 60% of the unimmunized children are living">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The TIP/Recommendation plan is being finalized with the EPI, and the implementation should start in January/2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">the ToR and implementation plan finalized, and validated, the field personal identified and trained.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the implementation of the recommendations of the tailoring immunization program (TIP).&#xA0; approach: the TIP was conducted in 2018-2019 in the three regions of Nouakchott where more than 60% of the unimmunized children are living">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The preparation work has started, but was temporarily suspended due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The supervisors and surveyors identified, and trained and the survey started</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the implementation of EVM (Efficacy Vaccine Management): the last EVM was conducted in 2016, and it is supposed to be conducted every 3 years. In addition to this, the EVM needs to be included in the country?s national immunization plan">
      <location ref="MR"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The EVM activity has not started yet du to Covid19 situation in the country including the immunization campaigns (Covid19 and HPV).
It is planned to be conducted by the end of March 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The implementation process of the cartography, and population demographic data review started/is being implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the creation of GIS tool (cartography) with the review of population demographic data for the three regions of Nouakchott">
      <location ref="MR"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The activity has not started yet du to Covid19 situation in the country including the immunization campaigns (Covid19 and HPV). It is planned to be conducted by the end of march 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The data collection tools revised, the plan is being implemented in two regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the implementation of the recommendations of the data quality review through a package of interventions that includes: the revision of data collection tools, data analysis/feedback, and supportive supervisions in the three less performing regions">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The preparation for the implementation of the recommendations of the data quality review is underway, and it is supposed to start in December 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The ToRs and implementation plan for MR surveillance and catch-up campaign finalized, and validated, the consultant and supporting personal identified</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the creation of GIS tool (cartography) with the review of population demographic data for the three regions of Nouakchott">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The preparation work has started, but was temporarily suspended due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">the ToR and implementation plan finalized, and validated, the consultant with the supporting team identified</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the implementation of EVM (Efficacy Vaccine Management): the last EVM was conducted in 2016, and it is supposed to be conducted every 3 years. In addition to this, the EVM needs to be included in the country?s national immunization plan">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The preparation work has started, but was temporarily suspended due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The data improvement plan finalized, with the identification of the regions, and supportive supervision chronogram</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the implementation of the recommendations of the data quality review through a package of interventions that includes: the revision of data collection tools, data analysis/feedback, and supportive supervisions in the three less performing regions">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The preparation work has started, but was temporarily suspended due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The country?s MR data analyzed, the poor performing regions/districts identified, the supportive supervisions started; and the catch-up MR campaign plan finalized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support measles and Rubella surveillance activities, the preparation of the upcoming MR
catch-up campaign, the MR national laboratory accreditation exercise, the training in laboratory data management, and&#xA0;the review of epidemiological surveillance system/EPI.
&#xA0;The last review was conducted in 2003, and it is recommended to do it every five years.">
      <location ref="MR"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The data are being collected for analysis, and the activity was delayed due to the Covid19 situation in the country., including the immunization campaigns (Covid19 and HPV).
The data analysis are planned to be finalized by the end of December, so the measles and rubella related activities can including the preparation of the MR catch up campaign can be conducted in January.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The ToRs and implementation plan for MR surveillance and catch-up campaign finalized, and validated, the consultant identified</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support measles and Rubella surveillance activities, the preparation of the upcoming MR
catch-up campaign, the MR national laboratory accreditation exercise, the training in laboratory data management, and&#xA0;the review of epidemiological surveillance system/EPI.
&#xA0;The last review was conducted in 2003, and it is recommended to do it every five years.">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The preparation work has started , but there is some delay due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">By June 2021, the DHIS2 is operational in all 57 districts (15 regions)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MoH to implement the DHIS2 in the remaining 13 regions, and the 45 districts">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">All the 13 regions, and the 45 districts data managers have been trained on the essential DHIS2 modules and the DHIS2 is being used in the 15 regions.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MoH to implement the DHIS2 in the remaining 13 regions, and the 45 districts">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">All the 13 regions, and the 45 districts data managers have been trained on the essential DHIS2 modules and the DHIS2 is being used in the 15 regions.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">the strategy to bring immunization services to nomadic populations developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support the ministry of health to map nomadic and seminomadic population and develop a strategy to bring them immunization services">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The preparation work has started in the regions where nomadic and semi-nomadic populations live, but was temporarily suspended due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support the ministry of health to map nomadic and seminomadic population and develop a strategy to bring them immunization services">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The preparation work has started in the regions where nomadic and semi-nomadic populations live, but was temporarily suspended due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The national MAP for all 46 targeted districts in the 15 regions for nomadic and seminomadic populations is developed in the GIS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support the ministry of health to map nomadic and seminomadic population and develop a strategy to bring them immunization services">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The preparation work has started in the regions where nomadic and semi-nomadic populations live, but was temporarily suspended due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">the ToRs and implementation plan for the AVW developed, implementing partners identified and documentation available for 30 persons in the 15 regions/56 districts trained on increasing awareness to strengthen immunization programs in their respective districts. the ToRs and implementation plan for the AVW developed, implementing partners identified and trained</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the ministry of health to implement the 2020 African Vaccination Week, the introduction of new vaccines, and enhance the technical capacities of the EPI staff at the central level (training workshops, )">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The HPV vaccine has been introduced in the EPI routine, and the post introductory evaluation is being prepared, and expected to be implemented by the end of July.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">the ToRs and implementation plan developed, implementing partners identified. Documentation available for the 12 persons from 12 regions, and trained on GIS use to map nomadic and seminomadic populations.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support the ministry of health to map nomadic and seminomadic population and develop a strategy to bring them immunization services">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The preparation work has started in the regions where nomadic and semi-nomadic populations live, but was temporarily suspended due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All the training modules revised and updated and ToRs and implementation plan finalized and the training started</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the MoH to train the EPI personal in the HSS2 districts/Regions, and in the regions of Dakhlet Nouadhibou and Tiris Zemour (these two regions were identified as priorities with regard to the training because of the personal that has never been trained on immunization technics">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The preparation work has started, but was temporarily suspended due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The 2021-2030 PNDS resource mobilization plan is available, project management will return to the WHO</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue to fund a Resource Mobilization Officer (r1-6)">
      <location ref="MR"></location>
     </target>
     <actual value="Completed">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">The resource mobilization officer is now fully funded by WHO.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">the ToR and the implementation plan finalized, and validated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the ministry of health to develop the national comprehensive multi-year strategic plans (cMYP) for immunization">
      <location ref="MR"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">This activity has not started yet due to the Covid19 situation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Un manuel de maintenance de la CDF y compris les SOP en mati&#xE8;re de logistique est &#xE9;labor&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Appui technique au d&#xE9;veloppement d&apos; un manuel de maintenance de la chaine de froid (CdF) y compris les SOP en mati&#xE8;re de logistique 
2. Appui &#xE0; l?organisation de la gestion efficace des vaccin (GEV) nationale
3. Appui technique &#xE0; la formation des techniciens de CdF des 15 r&#xE9;gions sur la maintenance des ECDF">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Le consultant est recrut&#xE9; , l&apos;activit&#xE9; est planifi&#xE9; dans POA et est dans la phase de revue documentaire</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Lerapport de la formation des techniciens de CDF sur la maintenance des ECDFs est disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Appui technique au d&#xE9;veloppement d&apos; un manuel de maintenance de la chaine de froid (CdF) y compris les SOP en mati&#xE8;re de logistique 
2. Appui &#xE0; l?organisation de la gestion efficace des vaccin (GEV) nationale
3. Appui technique &#xE0; la formation des techniciens de CdF des 15 r&#xE9;gions sur la maintenance des ECDF">
      <location ref="MR"></location>
     </target>
     <actual value="On Track">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Une mission pour l?inventaire des &#xE9;quipements de chaine de froid cruciale &#xE0; cause la r&#xE9;ception importante de quantit&#xE9; de vaccins anti-Covid-19 et la pr&#xE9;paration de la riposte &#xE0; l?&#xE9;pid&#xE9;mie PVDV2c L?analyse de l?outils d?inventaire montre que le GAP serait important si les &#xE9;quipements n?arrivent pas bient&#xF4;t. 
L?&#xE9;quipe a travaill&#xE9; sur l?&#xE9;laboration de proposal pour l?acquisition d?&#xE9;quipement dans le cadre du fonds japonais, HAC et USAID pour am&#xE9;liorer la chaine d?approvisionnement 
1.	Le manuel de proc&#xE9;dure op&#xE9;rationnelles standards est &#xE9;labor&#xE9; ainsi que le manuel de maintenance est en cours
2.	La pr&#xE9;paration de la GEV a &#xE9;t&#xE9; report&#xE9;e &#xE0; 2022 vue les fortes contraintes et la surcharge du personnel de vaccination et personnel de sant&#xE9;. 
3.	La formation des 15 points focaux a &#xE9;t&#xE9; retard&#xE9;e &#xE0; cause des restrictions de d&#xE9;placements du personnel &#xE0; cause de la flamb&#xE9;e du Covid- 19</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2. Data quality app installed
3. EPI legacy data migrated
4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="MR"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MR"></location>
      <comment>
       <narrative xml:lang="EN">Rescheculing process ongoing to adjust with dysruptions caused by Covid-19 pandemic and responsa activities. Additionnal activities proposal by MoH in discussion with HISP and may be shared with Gavi upon agreement</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2. Data quality app installed 3. EPI legacy data migrated 4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="MR"></location>
     </target>
     <actual>
      <location ref="MR"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Transition plan for EPI in place with agreed date for end of parallel system
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="MR"></location>
     </target>
     <actual>
      <location ref="MR"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
